
clavmaxxing
Iron
- Joined
- Dec 29, 2024
- Posts
- 21
- Reputation
- 25
PF-06252616 (Domagrozumab) is a myostatin inhibitor that could have revolutionized muscle growth by blocking a protein that limits muscle development. In theory, this compound would allow users to achieve insane muscle gains and faster recovery, similar to animals that lack myostatin. However, it was originally designed to treat Duchenne Muscular Dystrophy (DMD), a muscle-wasting disease, rather than for performance enhancement in healthy individuals. Clinical trials for its use in DMD showed no significant improvements, leading Pfizer to discontinue it in 2018.
RIP[EDIT]:https://www.medchemexpress.com/doma...0m6n6ERO3f_19uJjNw_31kKv0ox3NykYh0Wu_-DODlay8
YOU CAN BUY IT FOR "Research purposes" SAME WAY YOU CAN BUY STUFF OFF ResearchEM for research purposes,
Last edited: